CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-13 | Levy Adam Scott CFO and Secretary | Sale 10b5-1 | −3,392 | $42.26 | $143K | 116,865 |
| 2025-10-13 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −13,548 | $42.63 | $578K | 832,857 |
| 2025-10-13 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −1,552 | $43.03 | $67K | 831,305 |
| 2025-09-15 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −9,302 | $35.90 | $334K | 83,589 |
| 2025-09-15 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −2,065 | $36.47 | $75K | 81,524 |
| 2025-09-04 | AKKARAJU SRINIVAS Director | Purchase | +588,235 | $25.50 | $15.0M | 588,235 |
| 2025-09-04 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,176,470 | $25.50 | $30.0M | 5,456,521 |
| 2025-08-13 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −11,365 | $12.93 | $147K | 92,891 |
| 2025-08-12 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +6,349 | $1.08 | $7K | 104,256 |
| 2025-08-12 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −6,349 | 82,531 | ||
| 2025-07-30 | Levy Adam Scott CFO and Secretary | Sale | −51,500 | $14.70 | $757K | 141,359 |
| 2025-07-30 | Levy Adam Scott CFO and Secretary | Sale | −8,425 | $15.10 | $127K | 132,934 |
| 2025-07-29 | Levy Adam Scott CFO and Secretary | Sale | −807 | $14.00 | $11K | 192,859 |
| 2025-07-28 | Levy Adam Scott CFO and Secretary | Sale | −12,946 | $14.04 | $182K | 193,666 |
| 2025-07-14 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +6,349 | $1.08 | $7K | 109,273 |
| 2025-07-14 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −11,366 | $14.59 | $166K | 97,907 |
| 2025-07-14 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −6,349 | 88,880 | ||
| 2025-07-11 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −15,884 | $14.51 | $230K | 846,405 |
| 2025-07-11 | Levy Adam Scott CFO and Secretary | Sale 10b5-1 | −10,758 | $14.45 | $155K | 206,612 |
| 2025-06-13 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −11,366 | $14.60 | $166K | 101,651 |
Page 13 of 17 · 321 trades